A clinical study for a new needle-free glucagon for treatment of severe hypoglycemia in people on insulin is being conducted at several centers in the US. The study is currently seeking adults (18-65 years of age) with type 2 diabetes who have been on multiple daily injections of insulin for at least 2 years. If you are interested in learning more about this study, please visit the following listing of the study at ClinicalTrials.gov
